학술논문

87P Infliximab use in patients with checkpoint inhibitor toxicities: A tertiary centre experience
Document Type
Abstract
Source
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Subject
Language
ISSN
2590-0188